FRANKLIN LAKES, N.J., Nov. 14, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will host an institutional investor and analyst meeting on Thursday, November 17, 2016 in New York City from 8:30 a.m. – 3:30 p.m. (ET). The meeting will update the investment community on BD's plans to create long term value for its shareholders.
A live webcast of the event will be accessible through BD's website at www.bd.com/investors. A replay of the webcast will be available through Thursday, November 24, 2016.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Kristen Cardillo, Corporate Communications – 201-847-5657
Monique N. Dolecki, Investor Relations – 201-847-5378
SOURCE BD (Becton, Dickinson and Company)